2019•Trends in Urology & Men s HealthOpen access

Biologic treatments for rheumatoid arthritis

Jalpa Kotecha, Patrick D W Kiely

Abstract

Biologic disease‐modifying antirheumatic drugs (bDMARDs) have made a significant difference to the lives of people with rheumatoid arthritis (RA), in particular those who do not respond to conventional drugs. In this article the authors review the place in therapy of bDMARDs for RA and consider a range of factors that could contribute to further improvements to patient otucomes.

Open-access reader

About this research paper

What this paper is about

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Rheumatoid arthritis, Antirheumatic drugs, Medicine, Antirheumatic Agents, Biologic Agents, Intensive care medicine, Physical therapy, Internal medicine